Impact of the COVID-19 pandemic on antidiabetic drugs initiation in Sweden, an interrupted time series study

Data Availability

The data underlying this article cannot be shared publicly due to their containing sensitive information that could compromise the privacy of research participants. Analysis data will be shared upon reasonable request to the authors. Access to similar data requires permission. Apart from ethical approval from the Swedish Ethical Review Authority, researchers will also need approval from each register holder.